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Abstract
Background: Maternal measles antibodies (MMA) are actively transferred through the placenta from mother to foetus. A
relationship could exist between MMA of mother-infant pairs and maternal nutritional indicator (haemoglobin).
Objectives: This study reviewed the effects of maternal haemoglobin (Hb) on MMA of mother-infant pairs at birth.
Methods: One hundred and fifty three mother-infant pairs were enrolled in this study using the systematic random
sampling method. Means of maternal Hb and MMA of mother-infant pairs were compared using the Student t test.
Correlation coefficients of maternal Hb and MMA of mother-infant pairs were also determined. Multivariate analysis of
variable (MANOVA) and covariates (MANCOVA) was used to investigate the effects of  maternal Hb (fixed factor), gestational
age, maternal age, birth weight (covariates) on combined MMA of mother-infant pairs (dependent factors). Benferroni
adjusted Univariate linear regression was used to investigate the dependent variables separately.
Results: There were 78 (51%) males and 75 (49%) females.  The (mean ± SD) MMA of mother-infant pairs at birth were
134.66 ± 93.31 (95% CI, 119.76 – 149.56) U/ml, and 187.49 ± 85.01 (95% CI, 173.91 - 201.07) U/ml, and their correlation
was significant (p = 0.025). Ninety one (59.5 %) mothers had low Hb, 62 (40.5 %) had acceptable Hb levels. The overall
mean maternal Hb was 11.01 ± 1.00 (95% CI, 10.85 – 11.17) g/dl . A positive significant correlation was observed between
maternal Hb and MMA of  the newborn-infant (p = 0.031). The MANOVA showed a statistically significant difference
between maternal Hb on the combined dependent variables (p =0.033); however, results for the dependent variables using
the Benferroni adjusted Univariate analysis was significant for only MMA of the infants, (p = 0.009).
Conclusion: There was a significant association between aacceptable levels of maternal Hb and high MMA of the newborn-
infants. Therefore, these newborn infants start out with higher MMA that could give them better protection against measles
during infancy.
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Measles is one of the most common communicable
diseases and one of the major killers of infants in
the world particularly in developing countries. Live
attenuated measles vaccine is highly protective in
preventing measles.1 Transplacental transfer of
maternal measles antibodies (MMA) may protect
infants against measles during infancy.2 Sadly, the
transplacental transfer of MMA in mother-infant
pairs is affected by numerous factors that may
include poor nutrition.3 Measles is high in
malnourished population most especially those found
in tropical countries of  the world.4, 5 Possibly due to
high prevalence of malnutrition associated with these
countries.4, 5 Low haemoglobin (Hb) anaemia as an
indicator of malnutrition causes diminished immune
response to measles virus (MV), and this could lead
to decreased levels of measles antibodies in a
population.6
Poor nutrition and rapid loss of  MMA in
developing countries prompted suggestion for
review of the existing immunization practices for
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measles.7 Malnutrition is one of  the major public
health problems and it is one of the leading cause
of morbidity and mortality in Nigeria.8, 9 This may
not be unconnected to high poverty rate existing in
Nigeria.8 Different methods of estimating
malnutrition in countries yielded high proportions
of  individuals with malnutrition. For instance, in
Maiduguri, the prevalence of malnutrition was put
at 36% using the modified Wellcome’s classification.9
Other workers using the Gomez classification,
however, documented 47% cases of malnutrition
elsewhere.1 Estimation of Hb is a standard
laboratory measure and good indicator that can give
an idea about overall nutritional status of individuals
in a community.10 Whereas the prevalence of
malnutrition could vary from place to place, dearth
of knowledge still exist world-wide on the extent
to which maternal malnutrition affects  MMA in
mother-infant pairs particularly in our setting that is
measles endemic.
Therefore, this work looked at the effects
of maternal Hb as an indicator of maternal nutrition
on MMA of  mother-infant pairs at birth. To the
best of our knowledge there is no study on this
subject matter especially in North-Eastern Nigeria
and the country at large.
Methods
Study area
The study was carried out at the Department of
Paediatrics and Obstetrics unit of the University of
Maiduguri Teaching Hospital (UMTH), Nigeria. The
UMTH is a tertiary centre located in North-Eastern
Nigeria and a centre of excellence for infectious
diseases and immunology. It also serves as a referral
site for the six North-Eastern States of Nigeria and
the neighboring countries of Chad, Cameroon and
Niger Republics.
Study design
The study was a hospital-based comparative cross
sectional study of mother-infant pairs recruited from
the labour ward of the UMTH.
Ethical issues
The study protocol was reviewed and authorised
by the Medical Research and Ethics Committee of
UMTH, and informed consent from parents was
also obtained. Parents had unlimited liberty to deny
consent without any consequences and confidentiality
was maintained.
Sample size/Subject selection
The minimum sample size was determined using a
statistical formula, which detects differences between
two means when using paired sampling units: the
effect size was set at 0.2, alpha level at 0.05 and
power at 90%.11 However, 45% of the calculated
minimum sample was added to maximize power.
Therefore, the sample size for this study was one
hundred and fifty-three mother-infant pairs.
Consenting women who delivered vaginally at the
UMTH were enrolled for this study. Severely sick
pregnant women, those diagnosed with ante-partum
haemorrhage, those delivering stillborns and mothers
who had received blood transfusion during
pregnancy were excluded.
Data collection procedure
Mother-infant pairs were enrolled in this study using
the systematic random sampling method where the
first of every three mother-infant pair was picked at
the labour ward. Where the first mother did not
fulfil the inclusion criteria, the immediate next mother
that qualified was selected.  On enrolment of the
mother-infant pairs, study proforma were
administered to the mothers to collect information
on their bio-data, pregnancy history and antenatal
care history. Dubowitz Score was used to access the
gestational age (GA) of the newborn infants at birth,
12 and their birthweight (BW) was measured using
the basinet weighing scale that has a sensitivity of 50
grams. Newborn infants with GA less than 37
completed weeks were classified as preterm, those
from 37 completed to less than 42 completed weeks
were term, and those with 42 completed weeks or
more were post term. 12, 13 Newborns weighing >
3.99 kilograms were classified as macrosomia, those
weighing 2.5 – 3.99 kilogram as normal and those
< 2.5 kilogram were termed low BW.13
Collection of Samples
Three millilitres (mls) of venous blood were obtained
from the mothers on admission using sterile
disposable five mls syringe under aseptic technique.
Of the three mls of maternal venous blood drawn,
one ml was placed in ethylenediaminetetracetic acid
(EDTA) bottle. This blood was used for the
estimation of haemoglobin (Hb) concentration in
grams per decilitre (g/dl) using the micro-
haematocrit method.14 Low Hb is defined as Hb <
11g/dl, while acceptable Hb is Hb > 11g/dl.15 The
remaining two mls of maternal venous blood were
placed in sterile plain bottles and serum was separated
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after centrifuging the blood samples at 5000
revolutions per minute (rpm) for five minutes. The
sera obtained from maternal blood samples were
used for the analysis of MMA using enzyme linked
immunosorbent assay (ELISA).
Three millilitres of blood samples were also
obtained from the umbilical cord of the newborn
infants for the estimation of MMA. This was done
after centrifuging the blood samples and the
subsequent separation of the serum of the newborn
cord blood. All blood samples collected were stored
in a refrigerator at -20°C until the time of MMA
assay.
Statistical analysis
Statistical analyses were performed by use of  SPSS
statistical software version 16, Illinois, Chicago USA.
Values were expressed as percentages, mean ±
standard deviation (SD) and range. Means of
maternal Hb and MMA of mother-infant pairs were
compared using the Student t test. Correlation
coefficients of maternal Hb and MMA of mother-
infant pairs were also determined. Preliminary checks
were conducted to ensure that there was no violation
of  the assumptions of  normality, linearity,
homogeneity of variances, homogeneity of
regression slopes, and reliable measurement of the
covariate. Multivariate analysis of variance
(MANOVA) and covariates (MANCOVA) was used
to investigate the effects of maternal Hb (fixed
factor), GA, MA, BW (covariates) on combined
MMA of mother-infant pairs (dependent factors).
Benferroni adjusted Univariate linear regression
model was used to investigate the dependent variables
separately.  A p value < 0.05 was considered
significant. Tables were used appropriately for
illustration.
Results
One hundred and fifty three mother-infant pairs
were enrolled in this study. There were 78 (51%)
males and 75 (49%) female newborn infants giving
an approximate male to female ratio of 1.04:1.
Thirteen (8.5%), 138 (90.2%) and 2 (1.3%) newborn
infants were preterm, term and postterm deliveries.
Similarly, 17 (11.11%), 130 (84.97) and 6 (3.92%)
newborn infants were low BW, normal and
macrosomic deliveries. Table 1 shows the mean and
range values of  the study group. Maternal age ranges
from 17 to 37 years, the mean MMA of mother-
infant pairs was 134.66 ± 93.31 (95% CI, 119.76 –
149.56) U/ml and 187.49 ± 85.01 (95% CI, 173.91
- 201.07) U/ml respectively in a ratio of 1:1.3.
Correlation of these MMA was significant (r = 0.182,
p = 0.025) as shown in table 2.
Table 1: Mean and range values of  the study group
Parameters Mean ± SD        95% CI Range
GA (weeks) 38.78 ± 1.83 38.49 – 39.07 30 - 43
MA (years) 23.58 ± 4.9 22.78 – 24.38 17 - 37
BW (Kg) 3.06 ± 0.57 2.97 – 3.15 1.25 – 4.60
MMA (U/ml) 134.66 ± 93.31 119.76 – 149.56          -
MMA of Newborns (U/ml) 187.49 ± 85.01 173.91 - 201.07           -
SD = Standard deviation, CI = Confidence interval, GA = Gestational age, MA = Maternal age, BW = Birth
weight, MMA = Maternal measles antibodies
Table 2: Correlation of  maternal haemoglobin and maternal measles antibodies of  mother-infant
pairs
Maternal Mothers MMA          Newborns MMA
Hb (g/dl) (U/ml)                       (U/ml)
Maternal Hb (g/dl)                    r   0.036                         0.174
p   0.658                         0.031*
Mothers MMA r                                    0.182
(U/ml) p                                    0.025*
Newborns  MMA r
(U/ml) p
Hb = Haemoglobin   MMA = Maternal measles antibodies   *= p value < 0.05 (significant)
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Of the 153 (100 %) mothers that participated in this
study, 91 (59.5 %) were found to have low Hb (<
11g/dl), and 62 (40.5 %) had acceptable Hb levels (
> 11g/dl ). The overall mean maternal Hb was 11.01
± 1.00 (95% CI, 10.85 – 11.17) g/dl. Table 3 shows
the comparison between maternal Hb and mean MMA
of  mother-infant pairs. The mean MMA of  mother-
infant pairs were higher for mothers who had
acceptable Hb and low for mothers having low Hb.
However, the differences in mean MMA was only
significant in newborn infants of mothers with
acceptable Hb and low Hb (p = 0.002).
A positive correlation also existed between
maternal Hb and MMA of  mother-infant pairs.
However, this correlation was only significant for
maternal Hb and MMA of the newborn infants (r =
0.174, p = 0.031) table 2.
Table 4 shows a statistically significant
difference between maternal Hb on the combined
dependent variables: F = 3.490, p = 0.033; Wilks’
Lambda= 0.955; partial eta squared= 0.045. No
significant difference was observed between the
covariates (GA, MA and BW) on combined dependent
variables. When the results for the dependent variables
were considered separately, the only difference to
reach statistical significance using a Bonferroni adjusted
alpha level of 0.04, was the relationship between
maternal Hb and MMA of the infants: F = 7.027, p
= 0.009, partial eta squared = 0.045 (table 5). No
significant difference was observed between the
covariates and the dependent variables separately.
Table 3: Comparison between maternal haemoglobin and mean maternal measles antibody of  mother-
infant pairs
Maternal Hb (g/dl) Mean maternal measles antibodies ± SD (U/ml)
Mothers                  Newborn infants p value
Acceptable Hb (g/dl) 127.21± 63.38 227.40 ± 29.98 0.000*
( Hb > 11g/dl)
Low Hb (g/dl) 117.32 ± 59.19 175.98 ± 53.29 0.005*
(Hb  < 11g/dl)
p value 0.651 0.002*
Hb = Haemoglobin    *= p value < 0.05 (significant)
Table 4: Multiple tests of  effect of  maternal haemoglobin, maternal age, gestational age, birth
weight on maternal measles antibodies of  mother-infant pairs at birth
Effect Value F Hypo- Error df Sig.       Partial Eta
thesis df Squared
Intercept Pillai’s Trace 0.010 0.737a 2.000 147.000 0.480 0.010
Wilks’ Lambda 0.990 0.737a 2.000 147.000 0.480 0.010
Hotelling’s Trace 0.010 0.737a 2.000 147.000 0.480 0.010
Roy’s Largest Root 0.010 0.737a 2.000 147.000 0.480 0.010
MA Pillai’s Trace 0.001 0.075a 2.000 147.000 0.927 0.001
Wilks’ Lambda 0.999 0.075a 2.000 147.000 0.927 0.001
Hotelling’s Trace 0.001 0.075a 2.000 147.000 0.927 0.001
Roy’s Largest Root 0.001 0.075a 2.000 147.000 0.927 0.001
GA Pillai’s Trace 0.008 0.584a 2.000 147.000 0.559 0.008
Wilks’ Lambda 0.992 0.584a 2.000 147.000 0.559 0.008
Hotelling’s Trace 0.008 0.584a 2.000 147.000 0.559 0.008
Roy’s Largest Root 0.008 0.584a 2.000 147.000 0.559 0.008
BW Pillai’s Trace 0.002 0.179a 2.000 147.000 0.836 0.002
Wilks’ Lambda 0.998 0.179a 2.000 147.000 0.836 0.002
Hotelling’s Trace 0.002 0.179a 2.000 147.000 0.836 0.002
Roy’s Largest Root 0.002 0.179a 2.000 147.000 0.836 0.002
Maternal Hb Pillai’s Trace 0.045 3.490a 2.000 147.000 0.033* 0.045
Wilks’ Lambda 0.955 3.490a 2.000 147.000 0.033* 0.045
Hotelling’s Trace 0.047 3.490a 2.000 147.000 0.033* 0.045
Roy’s Largest Root 0.047 3.490a 2.000 147.000 0. 033* 0.045
a. Exact statistic Gestational age, b. Design: Intercept + MA +GA +BW +Maternal Hb
MA = Maternal age, BW = Birthweight, Hb = Haemoglobin  *= p value < 0.05 (significant)
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Table 5: Univariate tests of  between-subjects effects
Source Dependent Type III Sum df Mean F Sig.       Partial Eta
Variable  of squares           square                                             Squared
Corrected Model MMA 14450.362a 4 3612.591 0.408 0.802 0.011
Newborn MMA 52111.333b 4 13027.833 1.843 0.124 0.047
Intercept MMA 542.409 1 542.409 0.061 0.805 0.000
Newborn MMA 9007.171 1 9007.171 1.274 0.261 0.009
MA MMA 1151.523 1 1151.523 0.130 0.719 0.001
Newborn MMA 44.804 1 44.804 0.006 0.937 0.000
GA MMA 10339.637 1 10339.637 1.169 0.281 0.008
Newborn MMA 82.501 1 82.501 0.012 0.914 0.000
BW MMA 2099.622 1 2099.622 0.237 0.627 0.002
Newborn MMA 1323.611 1 1323.611 0.187 0.666 0.001
Maternal Hb MMA 1727.031 1 1727.031 0.195 0.659 0.001
Newborn MMA 49681.788 1 49681.788 7.027 0.009* 0.045
Error MMA 1309085.964 148 8845.175
Newborn MMA 1046450.902 148 7070.614
Total MMA 4097939.000 153
Newborn MA 6476906.000 153
Corrected Total MMA 1323536.327 152
Newborn MMA 1098562.235 152
a. R Squared = .011 (Adjusted R Squared = -.016 b. R Squared = .047 (Adjusted R Squared = .022)
*= p value < 0.05 significant,  Hb = Haemoglobin, GA = Gestational age, MA = Maternal age
BW = Birth weight, MMA = Maternal measles antibodies
Discussion
Present study revealed a high MMA in mother-infant
pairs at birth, with newborn infants having higher
levels of  MMA than their corresponding mothers.
This is similar to the observations that were made in
Lagos, Nigeria three decades ago and from other
studies conducted in other parts of the world.1, 16, 17
Active placental transfer of MMA from mothers to
their foetuses could be the likely explanation for the
newborn infants having higher MMA than their
mothers.18 The high levels of  MMA that was found
in the study population could be as a result of the
boosting effect of  MMA by MV, stemming from
the fact that measles is endemic in our setting.7, 17, 18
Whereas, acceptable maternal Hb yielded
higher mean MMA, low maternal Hb was associated
with low MMA of mother-infant pairs in this work.
Maternal Hb, in fact, was found to contribute
significantly towards newborn-infants having much
more MMA than their mothers. This conformed to
the observation made by other authors’ in both
developed and resource poor countries of the
world.17-19 The transfer of macromolecules from
mother to their foetuses via the placenta in most
cases is a reflection of maternal nutrition. The placenta
exerting activating mode of action towards
preferential concentration of some macromolecules
in the foetus.19 In this regard, MMA being
macromolecules would be better passed from
mother to foetus where maternal Hb is acceptable
relative to mothers with low Hb since maternal Hb
is a good indicator of maternal nutrition.1
Apart from being a good indicator of
mother’s health and nutrition, maternal Hb also has
a long-term health benefit in babies. This could
include newborn infants starting out with high levels
of MMA.1, 17-18 The present study showed that infants
of mal-nourished mothers (low Hb) are more prone
to measles. Reason being that, these newborn infants
are delivered with lower MMA; these antibodies may
not last long enough to protect them against measles
during infancy.18 The low MMA in infants whose
mothers have low Hb are further cleared by
overwhelming and recurrent infections among other
causes, thereby, making these children highly
vulnerable to measles and its complication chief
amongst them malnutrition.18, 20  Growth faltering
and developmental delay subsequently sets in in those
who continue to be malnourished following measles
in this vulnerable group.
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Even though the mean MMA of mother-
infant pairs of cohorts having low maternal Hb was
low compared to subjects whose mothers had high
(acceptable) Hb, their mean MMA was, nonetheless,
protective in present study. Similar finding was made
by victor et al, 18 in the year 2000. Mothers that were
found with low Hb in this study could still be
producing measles antibodies probably from
exposure to MV. Moreover, some workers have
found that humoral immunity is not impaired even
under acute nutritional stress.21 This means that,
mothers with low Hb as seen in our study could
respond to MV challenge by producing high levels
of  MMA, which are transferred to their babies.
Maternal age, GA and BW did not
significantly affect MMA of mother-infant pairs in
this work. Other workers had reported similar
findings with respect to MA and BW, however, GA
age was found to vary directly with MMA in mother-
infant pairs. 1, 16-18 The possible explanation for our
observation may be that most of  the mothers are
very young in their twenties, majority of the newborn
infants are term and with normal BW. The transfer
of MMA in mother-infant pair across the placenta
occurs maximally from the third trimester of
pregnancy that is from 28 weeks of gestation
onward. 1, 16, 17 The least GA in this study was 30
weeks and since the study was not primarily design
to compare MA, GA and BW with MMA of
mother-infant pairs, our finding in this regard is
anticipated.
Most developing and sub-Saharan countries
like Nigeria are saddled with malnutrition and high
cases of  measles. The scourge of  measles and its
complications, such as malnutrition in children from
these poor nations could be reduced if mothers
thought of health values like adequate nutrition. These
would ensure acceptable Hb levels in mothers, which
could in turn generate high levels MMA. Information
obtained from this study may be of public health
benefit because policy makers can use this work as a
platform to improve on the existing maternal health
practices geared towards improving maternal
nutrition. By improving maternal nutrition, higher
levels of MMA could be generated, which could
prevent infants from measles.
Conclusion
 Mothers with acceptable Hb gave birth to newborn
infants with higher levels of MMA compared to the
low levels of  MMA observed in newborns whose
mothers had low Hb. Thus, newborn infants of
mothers with acceptable Hb in the current work have
better protection against measles.
Limitations
This work was performed at the UMTH, which
makes it a uni-centered study. This is a setback because
caution is needed in generalizing the results of this
research. Data on MA, GA and BW were skewed
towards very young MA, term deliveries and normal
BW. These could be another drawback because
skewed distribution of  data is a shift from normal
population distribution that may interfere with the
interpretation of  results.
Recommendations
In order to eliminate measles in children in our setting,
there is need for relevant authorities to re-strategize
and implement maternal health practices like adequate
nutrition. The girl child should be educated and be
well informed on good nutritional habits. This will
help in generating acceptable maternal Hb and high
levels of MMA needed to protect infants against
measles during the child bearing age of the girl child.
Studies of this kind in the future should include
mother-infant pairs from multiple health centers in
order to have a representative cross-section of the
study population. Furthermore, a study design that
accommodates all MA groups within the child
bearing age, GA groups and BW groups in greater
frequencies is also recommended in order to improve
the power of the relationship between these variables
and MMA.
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